Contrast nephropathy: Review focusing on prevention

Journal of the American College of Cardiology

Volumn 44, Issue 9, 2004, Pages 1763-1771

  Maeder, Micha ^a,b   Klein, Maja ^b   Fehr, Thomas ^c   Rickli, Hans ^a  

^a Division of Cardiology   (Switzerland)

^b CANTONAL HOSPITAL ST GALLEN   (Switzerland)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; ADENOSINE RECEPTOR BLOCKING AGENT; CONTRAST MEDIUM; CREATININE; DIURETIC AGENT; DOPAMINE; DOPAMINE RECEPTOR STIMULATING AGENT; FENOLDOPAM; FUROSEMIDE; IODIXANOL; IOHEXOL; IOPAMIDOL; IOPROMIDE; IOVERSOL; IOXAGLIC ACID; MANNITOL; MEGLUMINE DIATRIZOATE; MEGLUMINE DIATRIZOATE PLUS SODIUM DIATRIZOATE; MEGLUMINE IOXAGLATE PLUS SODIUM IOXAGLATE; OPITRAY; PLACEBO; THEOPHYLLINE;

CLINICAL TRIAL; CONTRAST NEPHROPATHY; CREATININE BLOOD LEVEL; CYTOTOXICITY; DIABETIC NEPHROPATHY; DISEASE PREDISPOSITION; DIURESIS; DOSE RESPONSE; HEMODIALYSIS; HEMOFILTRATION; HUMAN; HYDRATION; HYPOVOLEMIA; HYPOXIA; KIDNEY BLOOD FLOW; KIDNEY DISEASE; KIDNEY FAILURE; MORBIDITY; MORTALITY; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROPHYLAXIS; REVIEW; RISK FACTOR; TACHYCARDIA;

CONTRAST MEDIA; HUMANS; KIDNEY FAILURE, ACUTE; PRIMARY PREVENTION; REVIEW LITERATURE; RISK FACTORS;

EID: 7044245840     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2004.06.075     Document Type: Review

References (66)

1. S.H. Hou, D.A. Bushinsky, J.B. Wish, J.J. Cohen, J.T. Harrington Hospital acquired renal insufficiency: a prospective study Am J Med 74 1983 243 248
2. C.S. Rihal, S.C. Textor, D.E Grill Incidence and prognostic importance of acute renal failure after percutaneous coronary intervention Circulation 105 2002 2259 2264
3. L. Gruberg, R. Mehran, G Dangas Acute renal failure requiring dialysis after percutaneous coronary interventions Cathet Cardiovasc Intervent 52 2001 409 416
4. P.A. McCullough, R. Wolyn, L.L. Rocher, R.N. Levin, W.W. O'Neill Acute renal failure after coronary intervention: incidence, risk factors, and relationship to mortality Am J Med 103 1997 368 375
5. R.N. Foley, P.S. Parfrey, M.J. Sarnak Clinical epidemiology of cardiovascular disease in chronic renal failure Am J Kidney Dis 32 1998 S112 9
6. W. Huber, C. Schipek, K Ilgmann Effectiveness of theophylline prophylaxis of renal impairment after coronary angiography in patients with chronic renal insufficiency Am J Cardiol 91 2003 1157 1162
7. M.R. Rudnick, S. Goldfarb, L Wexler Nephrotoxicity of ionic and nonionic contrast media in 1,196 patients: a randomized trial Kidney Int 47 1995 254 261
8. C.L. Manske, J.M. Sprafka, J.T. Strony, Y. Wang Contrast nephropathy in azotemic diabetic patients undergoing coronary angiography Am J Med 89 1990 615 620
9. J. Brinker What every cardiologist should know about intravascular contrast Rev Cardiovasc Med 4 Suppl 5 2003 S19 27
10. S.N. Heyman, S. Rosen, M. Brezis Radiocontrast nephropathy: a paradigm for the synergism between toxic and hypoxic insults in the kidney Exp Nephrol 2 1994 153 157
11. K. Arakawa, H. Suzuki, M Naitoh Role of adenosine in the renal response to contrast medium Kidney Int 49 1996 1199 1206
12. P.A. Cullough Cardiorenal risk: an important clinical intersection Rev Cardiovasc Med 3 2002 71 76
13. Heart Outcome Prevention Evaluation Study Investigators Effects of ramipril on cardiovascular and microvascular outcome in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy Lancet 355 2000 253 259
14. B.M. Brenner, M.E. Cooper, D., et al de Zeeuw., for the RENAAL Study Investigators Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy N Engl J Med 345 2001 861 869
15. H.D. Humes, D.A. Hunt, M.D. White Direct toxic effects of the radiocontrast agent diatrizoate on renal proximal tubule cells Am J Physiol 252 1987 F246 55
16. P. Liss, A. Nygren, U. Olsson, H.R. Ulfendahl, U. Erikson Effects of contrast media and mannitol on renal medullary blood blow and aggregation in the rat kidney Kidney Int 49 1996 1268 1275
17. I. Hizoh, J. Strater, C.S. Schick, W. Kübler, C. Haller Radiocontrast-induced DNA fragmentation of renal tubular cells in vitro: role of hypertonicity Nephrol Dial Transplant 13 1998 911 918
18. G. Deray, C. Bagnis, C. Jacquiaud, M. Dubois, Y. Adabra, C. Jaudon Renal effects of low and iso-osmolar contrast media on renal hemodynamics in a normal and ischemic dog kidney Invest Radiol 34 1999 1 4
19. B.J. Barret, E.J. Carlisle Meta-analysis on the relative nephrotoxicity of high- and low-osmolality iodinated contrast media Radiology 188 1993 171 178
20. P. Aspelin, P. Aubry, S.V. Fransson, R. Strasser, R. Willenbrock, K.T. Berg for the NEPHRIC Study Investigators Nephrotoxic effects in high-risk patients undergoing angiography N Engl J Med 348 2003 491 499
21. C. Mueller, G. Buerkle, H.J Buettner Prevention of contrast media-associated nephropathy Arch Intern Med 162 2002 329 336
22. R. Solomon, C. Werner, D. Mann, J. D'Elia, P. Silva Effects of saline, mannitol, and furosemide on acute decreases in renal function induced by radiocontrast agents N Engl J Med 331 1994 1416 1420
23. J.D. Durham, C. Caputo, J Dokko A randomized controlled trial of N-acetylcysteine to prevent contrast nephropathy in cardiac angiography Kidney Int 62 2002 2202 2207
24. F. Boccalandro, M. Amhad, R.W. Smalling, S. Sdringola Oral acetylcysteine does not protect renal function from moderate to high doses of intravenous radiographic contrast Catheter Cardiovasc Interv 58 2003 336 341
25. S. Allaqaband, R. Tumuluri, A.M Malik Prospective randomized study of N-acetylcysteine, fenoldopam, and saline for prevention of contrast-induced nephropathy Catheter Cardiovasc Interv 57 2002 279 283
26. I. Goldenberg, M. Shechter, S Matetzky Oral acetylcysteine as an adjunct to saline hydratation for the prevention of contrast-induced nephropathy following coronary angiography Eur Heart J 25 2004 212 218
27. K.J. Shyu, J.J. Cheng, P. Kuan Acetylcysteine protects against acute renal damage in patients with abnormal renal function undergoing a coronary procedure J Am Coll Cardiol 40 2002 1383 1388
28. C. Briguori, A. Colombo, A Violante Standard vs double dose of N-acetylcysteine to prevent contrast agent associated nephrotoxicity Eur Heart J 25 2004 206 211
29. J.B. Oldenmeyer, W.P. Biddle, R.L. Wurdemann, A.N. Mooss, E. Cichowski, D.E. Hillemann Acetylcysteine in the prevention of contrast-induced nephropathy after coronary angiography Am Heart J 146 2003 e23
30. L.J. Diaz-Sandoval, B.D. Kosowsky, D.W. Losordo Acetylcysteine to prevent angiography-related renal tissue injury (the APART trial) Am J Cardiol 89 2002 356 358
31. J. Kay, W.H. Chow, T.M Chan Acetylcysteine for prevention of acute deterioration of renal function following elective coronary angiography and intervention: a randomized controlled trial JAMA 289 2003 553 558
32. C. Briguori, F. Manganelli, P Scarpato Acetylcysteine and contrast agent-associated nephrotoxicity J Am Coll Cardiol 40; 2002 298 303
33. B.D. MacNeill, S.A. Harding, H Bazari Prophalyxis of contrast-induced nephropathy in patients undergoing coronary angiography Catheter Cardiovasc Interv 60 2003 458 461
34. C.S.R. Baker, A. Wragg, S. Kmar, R. De Palma, L.R.I. Baker, C.J. Knight A rapid protocol for the prevention of contrast-induced renal dysfunction: the RAPPID study J Am Coll Cardiol 41 2003 2114 2118
35. B. Vogt, P. Ferrari, C Schoenholzer Prophylactic hemodialysis after radiocontrast media in patients with renal insufficiency is potentially harmful Am J Med 111 2001 692 698
36. D.W. Cockcroft, M.H. Gault Prediction of creatinine clearance from serum creatinine Nephron 16 1976 31 41
37. A.S. Levey, J.P. Bosch, J.B. Lewis, T. Greene, N. Rogers, D. Roth A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation: modification of diet in renal disease study group Ann Intern Med 130 1999 461 470
38. V.R. Dharnidharka, C. Kwon, G. Stevens Serum cystatin C is superior to serum creatinine as a marker of kidney function: a meta-analysis Am J Kidney Dis 40 2002 221 226
39. H. Rickli, K. Benou, P Ammann Time course of cystatin levels in comparison with serum creatinine after application of radiocontrast media Clin Nephrol 61 2004 98 9102
40. M.K. Page, J. Bukki, P. Luppa, D. Neumeier Clinical value of cystatin C determination Clin Chim Acta 297 2000 67 72
41. E.L. Knight, J.C. Verhave, D Spiegelmann Factors influencing serum cystatin C levels other than renal function and the impact on renal function measurement Kidney Int 65 2004 1416 1421
42. F. Scolari, M. Bracchi, B Valzorio Cholesterol embolism: an increasingly recognized cause of acute renal failure Nephrol Dial Transplant 11 1996 1607 1612
43. Y. Fukumoto, H. Tsutsui, M. Tsuchihashi, A. Masumoto, A. Takeshita for the Cholesterol Embolism Study (CHEST) Investigators The incidence of cholesterol embolization syndrome, a complication of cardiac catheterization: a prospective study J Am Coll Cardiol 42 2003 211 216
44. C.M. Erley Does hydratation prevent radiocontrast-induced acute renal failure? Nephrol Dial Transplant 14 1999 1064 1066
45. A.J. Taylor, D. Hotchkis, R.W. Morse, J. McCabe PREPARED: preparation for angiography in renal dysfunction: a randomised trial of inpatient vs outpatient hydratation protocols for cardiac catheterisation in mild-to-moderate renal dysfunction Chest 114 1998 1570 1574
46. H.S. Trivedi, H. Moore, S Nasr A randomized prospective trial to assess the role of saline hydratation on the development of contrast nephropathy Nephron Clin Pract 93 2003 C29 34
47. G.J. Merten, W.P. Burgess, L.V Gray Prevention of contrast-induced nephropathy with sodium bicarbonate: a randomized controlled trial JAMA 291 2004 2328 2334
48. M. Gare, Y.S. Haviv, A Ben-Yehuda The renal effect of low-dose dopamine in high-risk patients undergoing coronary angiography J Am Coll Cardiol 34 1999 1682 1688
49. A. Abizaid, C.E. Clark, G.S Mintz Effects of dopamine and aminophylline on contrast-induced acute renal failure after coronary angioplasty in patients with preexisting renal insufficiency Am J Cardiol 83 1999 260 263
50. G.L. Bakris, N.A. Lass, D. Glock Renal hemodynamics in radiocontrast medium-induced renal dysfunction: a role for dopamine-1 receptors Kidney Int 56 1999 206 210
51. J.A. Tumlin, A. Wang, P.T. Murray, V.S. Mathur Fenoldopam mesylate blocks reductions in renal plasma flow after radiocontrast dye infusion: a pilot trial in the prevention of contrast nephropathy Am Heart J 143 2002 894 903
52. G. Stone, P. McCullough, J Tumlin Fenoldopam mesylate for the prevention of contrast-induced nephropathy: a randomised controlled trial JAMA 290 2003 2284 2291
53. W. Huber, K. Ilgmann, M Page Effect of theophylline on contrast material-nephropathy in patients with chronic renal insufficiency: controlled, randomized double-blinded study Radiology 223 2002 772 779
54. A. Kapoor, S. Kumar, S. Gulati, S. Gambhir, R.S. Sethi, N. Sinha The role of theophylline in contrast-induced nephropathy: a case control study Nephrol Dial Transplant 17 2002 1936 1941
55. C.M. Erley, S.H. Duda, D Rehfuss Prevention of radiocontrast-induced nephropathy in patients with pre-existing renal insufficiency by hydratation in combination with the adenosine antagonist theophylline Nephrol Dial Transplant 14 1999 1146 1149
56. B.R. Kurnik, R.L. Allgren, F.C. Genter, R.J. Solomon, E.R. Bates, L.S. Weisberg Prospective study of atrial natriuretic peptide for the prevention of radiocontrast-induced nephropathy Am J Kidney Dis 31 1998 674 680
57. M. Wang, T. Holcslaw, T.M Bashore Exacerbation of radiocontrast nephrotoxicity by endothelin antagonism Kidney Int 57 2000 1875 1880
58. M. Carraro, W. Mancini, M Artero Dose effect of nitrendipine on urinary enzymes and microproteins following non-ionic radiocontrast administration Nephrol Dial Transplant 11 1996 444 448
59. M. Tepel, M. Van der Giet, C. Schwarzfeld, U. Laufer, D. Liermann, W. Zidek Prevention of radiographic-contrast-agent-induced reductions in renal function by acetylcysteine N Engl J Med 343 2000 180 184
60. A. Alonso, J. Lau, B.L. Jaber, A. Weintraub, M.J. Sarnak Prevention of radiocontrast nephropathy with N-acetylcysteine in patients with chronic kidney disease: a meta-analysis of randomized, controlled trials Am J Kidney Dis 43 2004 1 9
61. A.V. Kshirsagar, C. Poole, A Mottl N-acetylcysteine for the prevention of radiocontrast induced nephropathy: a meta-analysis of prospective controlled trials J Am Soc Nephrol 15 2004 761 769
62. N. Pannu, B. Manns, H. Lee, M. Tonelli Systematic review of the impact of N-acetylcysteine on contrast nephropathy Kidney Int 65 2004 1366 1374
63. T. Lehnert, E. Keller, K. Gondolf, T. Schaffner, H. Pavenstadt, P. Schollmeyer Effects of haemodialysis after contrast medium administration in patients with renal insufficiency Nephrol Dial Transplant 13 1998 358 362
64. C. Marenzi, I. Marana, G Lauri The prevention of radiocontrast-agent- induced nephropathy by hemofiltration N Engl J Med 349 2003 1330 1340
65. H.S. Thomsen Guidelines for contrast media from the European Society of Urogenital Radiology Am J Roentgenol 181 2003 1463 1471
66. M. Billinger, O.M. Hess, B. Meier Prevention of contrast-induced renal dysfunction by N-acetylcysteine: truth or myth? Eur Heart J 25 2004 188 189